Takeda Pharmaceutical Company Limited vs Novartis AG
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Both companies need to be compared on revenue growth quality, margin trajectory and management commentary.
Takeda Pharmaceutical Company Limited and Novartis AG show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Takeda Pharmaceutical Company Limited | Novartis AG |
|---|---|---|
| Current Price | ₹16.15 | ₹151.4 |
| Market Cap | ₹50,828.88 Cr. | ₹2.89 L Cr. |
| Industry | Pharmaceuticals | Pharmaceuticals |
| P/E Ratio | 41.763157 | 21.604586 |
| ROE (%) | — | — |
| Debt/Equity | — | — |
| Sales Growth 5Y (%) | — | — |
| Profit Growth 5Y (%) | — | — |
| Promoter Holding (%) | — | — |
| Revenue Rank | Rank 4 | Rank 4 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |